References
- DeSombre ER, Carbone PP, Jensen EV et al: Special report; steroid receptors in breast cancer. N Engl J Med 301:1011–1012, 1979
- Knight WA, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recur-rence in breast cancer. Cancer Res 37:4669–4671, 1977.
- Thorpe SM: Estrogen and progesterone receptor determination in breast cancer. Technology, biology and clinical significance. Acta Oncol 27:1–20, 1988
- King WJ, DeSombre ER, Jensen EV, Greene GL: Comparison of immunocytochemical and steroid binding assays for estrogen receptor in human breast tumors. Cancer Res 45:293–304, 1985
- Leclercq G, Bojar H, Coussard J, Nicholson RI et al: Abbott monoclonal enzyme immunoassay for the measurement of es-trogen receptors in human breast cancer: A European Mul-ticenter Study. Cancer Res 46 (Suppl):4233s-4236s, 1986
- Ozello L, DeRosa C, Konrath JG et al: Detection of estrophilin in frozen sections of breast cancers using and estrogen receptor immunocytochemical assay. Cancer Res 46 (Suppl):4303s-4307s, 1986
- McGuire WL, Clark GM: Role of progesterone receptors in breast cancer. Semin Oncol 12:12–16, 1985
- Goussard J, Leeheverel C, Martin PM, Roussel G: Comparison of monoclonal antibodies and tritiated I igands for estrogen receptor assay in 241 breast cytols. Cancer Res 46 (Suppl): 4282s–4287s, 1986
- Alfred DC, Bustamente MA, Daniel CO et al: Immunocyto-chemical analysis of estrogen receptors in human breast carci-nomas. Evaluation of 130 cases and a review of the literature re-garding concordance with the biochemical assay and clinical relevance. Arch Surg 125:107–113, 1990
- Elias JM, Margiotta M, Sexton TR, Heimann A: Immuno-histochemical detection of sex steroid receptors in breast cancer using routine paraffin sections: Comparison with frozen sec-tions and enzyme immunoassay. J Cell Biochem Supplement 19:126–130, 1994
- Skovgaard P, Ozello L, King WJ, Greene GL: The use of mono-clonal antibodies to estrogen receptors (ER) for immunoperoxi-dase detection of ER in paraffin sections of human breast cancer tissue. J Histochem Cytochem 33:(2)87-92, 1985
- Elias JM, Heimann A, Canin T et al: Estrogen receptor localiza-tion in paraffin sections by enzyme digestion, repeated applica-tions of primary antibody, and imidazole. J Histechnol 12:29–33, 1990
- Raymond WA, Leong A S-Y: Oestrogen receptor staining of paraffin embedded breast carcinomas following short fixation in formal in : A comparison with cytosolic and frozen section receptor analysis. J Pathol 160:295–303, 1990
- Vollemer G, Gerdes J, Knuppen R: Quantitation of estrogen and progesterone receptors from cryostat sectioned human tumor tissue: Comparison of ligand binding and immunocytochemical assays. J Steroid Biochem 33:41–47, 1989
- King WJ, DeSombre ER, Jensen EV, Greene GL: Comparison of immunocytochemical and steroid binding assays for estrogen receptor in human breast tumors. Cancer Res 45:293–304, 1985
- Esteban JM, Battiffora H, Warsi L et al: Quantitation of estro-gen receptors on paraffin-embedded tumors by image analysis. Mod Pathol 4:53–57, 1991
- AlSaati T, Clamens S, Cohen-Knafo E et al: Production of monoclonal antibodies to human estrogen receptor (ER) using recombinant ER (RER). Int J Cancer 55:651–654, 1993
- Kell DL, Kamel OW, Rouse RV: immunohistochemical anal-ysis of breast carcinomas estrogen and progesterone receptors in paraffin-embedded tissue: correlation of clones ER I D5 and 1A6 with a cytosol-based assay hormone receptor assay. Appl Immunohistochem 1:275–281, 1993
- Hendricks JB, Wilkinson EJ: Comparison of two antibodies for evaluation of estrogen receptors in paraffin-embedded tumors. Mod Pathol 6:765–770, 1993
- Leong ASY, Millios J: Comparison of antibodies to estrogen and progesterone receptors and the influence of microwave an-tigen retrieval. Appl Immunohistochem 1:282–288, 1993
- Stierer M, Rosen H, Weber R et al: Immunohistochemical and biochemical measurements of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathol-ogy and prognostic factors. Ann Surg 218(1):13–21, 1993
- Poller DN, Snead DR, Roberts EC et al: Oestrogen receptor expression in ductal carcinoma in situ of the breast: relation-ship to flow cytometric analysis of DNA and expression of c-erbB-2 oncoprotein. Br J Cancer 68:156–161, 1993
- Elias JM, Cartum RA, England DM et al: Interlaboratory comparison of estrogen receptor analysis in paraffin sections by a monoclonal antibody to estrophilin (H222). J Histotech-nol 16:57–63, 1993
- Bosman FT, deGoeij AFPM, Rousch M: Quality control in immunocytochemistry: Experiences with the oestrogen recep-tor assay. J Clin Pathol 45:120–124, 1991
- Kinsel LB, Szabo E, Greene GL et al: Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: Comparison with quantitative biochem-ical methods. Cancer Res 49:1052–1056, 1989
- Tesch M, Shawa A, Henderson R: Immunohistochemical de-termination of estrogen and progesterone receptor status in breast cancer. Am J Clin Pathol 99:8–12, 1993
- Immunohistochemistry Survey Conducted by the College of American Pathologists 1993.
- Battifora H, Mehta P, Ahn C, Esteban JM: Estrogen receptor immunohistochemical assay in paraffin-embedded tissue. Appl Immunohistochem 1:39–45, 1993
- Miller RT, Hapke MR, Greene GL: Immunocytochemical as-say for estrogen receptor with monoclonal antibody D753P gamma in routinely processed formaldehyde-fixed breast tis-sue. Comparison with frozen section assay with monoclonal antibody H222. Cancer 71(11):3541– 3546, 1993
- Pelicer EM, Sundblad A: Evaluation of antibodies to estrogen receptors (Letter to Editor). Appl Immunohistochem 2(2): 1411994
- McGuire WL, Chamness GC, Fuqua SAW. Estrogen receptor in clinical breast cancer. Molec Endocrinol 5:1571–1577, 1991
- Kumar V., Green G, Stack G et al: Functional domains of the human estrogen receptor. Cell 51:941–951, 1987
- Miksicek RI: Steroid receptor varients and their potential role in cancer. Semin Cancer Biol 5:369–379, 1994
- Foekens JA, Portengen H, Look MA et al: Relationship of pS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br J Cancer 70:1217–1223, 1994